Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Forecast to 2031

icon1
USD 8.68 BN
MARKET SIZE, 2031
icon2
CAGR 6.7%
(2026-2031)
icon3
400
REPORT PAGES
icon4
380
MARKET TABLES

OVERVIEW

vascular-access-device-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The vascular access device market, valued at USD 5.92 billion in 2025, stood at USD 6.27 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.68 billion by the end of the period. The market's expansion is attributed to the increasing prevalence of chronic diseases requiring frequent or long-term treatment through IV, such as cancer, heart disease, and kidney failure. The increase in surgical operations and hospital stays, as well as the need for emergency and critical care, also adds to the market's continuous growth. The introduction of new technologies, such as safety-engineered devices, antimicrobial coatings, and improved catheter materials, is making the patient safer and the clinic more efficient, in turn increasing the use of such technologies. The growing elderly population, the development of hospital and home care practices, and the strong emphasis on infection control and economical treatment are other factors speeding up the demand for vascular access devices globally.

KEY TAKEAWAYS

  • By Type
    The peripheral vascular access device segment is expected to register the highest CAGR of 7.6% during the forecast period.
  • By Route of Insertion
    The intravenous route of insertion segment is expected to register the highest CAGR of 6.8% during the forecast period.
  • By Application
    The drug administration segment is estimated to account for the largest market share of 49.6% in 2025.
  • By End User
    The hospital segment is estimated to dominate the market with a share of 65.3% in 2025.
  • Competitive Landscape - Key Players
    The vascular access device market is highly competitive, dominated by key players such as Becton Dickinson & Company, Teleflex Incorporated, ICU Medical, Nipro Corporation, and Vygon. Becton Dickinson leads the market with its extensive product portfolio and strong global presence. Teleflex and ICU Medical focus on innovation and growth through product launches and strategic acquisitions, while Nipro and Vygon maintain a solid market position by offering a comprehensive range of vascular access devices across multiple regions.
  • Competitive Landscape - Startups
    Argon Medical Devices Inc.(US), PFM Medical (Germany), and Delta Med (Italy) are among the startups specializing in vascular access devices.

The vascular access device market's growth is mainly attributed to the increasing incidence of chronic diseases like cancer, diabetes, cardiovascular problems, and kidney failure requiring long-term or repeated intravenous treatments. In addition, demand for reliable vascular access devices is being fueled by the growing number of surgical procedures, hospital admissions, and emergency care. Besides, constant innovations such as safety-engineered designs, antimicrobial and antithrombogenic coatings, and ultrasound-guided insertion are not only improving clinical outcomes and minimizing complications but are also paving the way for the broader acceptance of these devices.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The overall market for vascular access devices (VADs) is growing at a steady pace, backed by the increasing requirement of modern healthcare systems, the fast technological innovations, and changing healthcare delivery models. The world's population is getting older, and with that comes an increased risk of chronic diseases such as cancer, heart conditions, diabetes, and renal failure. The need for short- and long-term vascular access has increased due to its importance in medical procedures like drug administration, chemotherapy, dialysis, and blood transfusions. Healthcare systems are realigning their focus to support less invasive and more effective treatment options, promoting advanced access solutions that reduce complications and enhance patient experiences. Technological advancements, including antimicrobial and antithrombogenic-coated catheters, safety-engineered designs, and ultrasound-guided insertion techniques, aim to enhance clinical outcomes and minimize infections and needlestick injuries. As infusion therapies shift toward outpatient clinics and home healthcare, the requirement for cost-effective vascular access devices is rising. Digital transformation, through smart infusion systems and data-driven protocols, is driving market growth. Manufacturers prioritize value-based care models and strict regulatory standards by focusing on innovation and product differentiation.

vascular-access-device-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing prevalence of lifestyle diseases
  • Increasing number of chemotherapy procedures
RESTRAINTS
Impact
Level
  • Product recalls and failures
  • High cost of placement and maintenance of vascular access devices
OPPORTUNITIES
Impact
Level
  • Technological advancements
  • Increasing number of hospitals and expanding patient pool
CHALLENGES
Impact
Level
  • Shortage of skilled healthcare professionals
  • Risks associated with vascular access devices

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing prevalence of lifestyle diseases

The global rise of unhealthy dietary practices and the absence of exercise has caused the spread of lifestyle-related diseases, notably diabetes and obesity, among others, linked to the abuse of smoking and alcohol. A case in point is the CDC's estimate that nearly 38.4 million individuals in the US were diabetic in 2021, of which 29.4 million were officially diagnosed. The world diabetes population, according to WHO, grew from about 200 million in 1990 to nearly 830 million in 2022. On top of that, the vascular access devices market in low- and middle-income countries is expanding at a faster rate because of the large patient populations and, thus, the need for advanced solutions to manage chronic diseases.

Restraint: Product recalls and failures

The vascular access device market is under pressure mainly because of the rising product recalls and failures, which are primarily the result of strict regulatory scrutiny from agencies like the FDA and CDSCO. One of the main issues is product malfunction since vascular access devices are in contact with blood, and such malfunctions may cause serious complications like infections, thrombosis, and even death. Therefore, the recall of several devices in various areas has adversely affected the market growth as well as the manufacturers’ reputation.

Opportunity: Technological advancements

Experience in placement and imaging methods was the main driver behind technological advancement in the vascular access device market. Nevertheless, ultrasound, which is a non-invasive and readily available technique, has turned out to be one of the best visualization methods for vascular access. The cost-effectiveness and high efficiency of image-guided vascular access have made it easy to accurately evaluate vein maturity and detect complications early, thus increasing the precision of procedures and the quality of patient outcomes.

Challenge: Shortage of skilled professionals

One of the biggest hurdles restraining the growth of the market is the worldwide lack of qualified healthcare workers skilled in vascular access, such as nurses, doctors, and other specialists. Wrongly placing a vascular access device can cause very serious damage, such as vessel damage, bleeding, air embolism, pneumothorax, and infection of the bloodstream. The rise in demand for complicated procedures is making the situation even worse. One key reason for the shortage of skilled workers is the lack of medical training in emerging markets. As a result, these regions may struggle to keep up with new technologies and treatments in the vascular access device field. Consequently, the demand for skilled medical staff will not diminish as quickly as the availability of these devices.

VASCULAR ACCESS DEVICE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Portfolio spans closed PIVC systems (Nexiva) and ultrasound-guided midlines (PowerGlide Pro) for extended peripheral therapy and streamlined insertion workflows. Closed, integrated design supports longer dwell and reduced blood exposure/needlestick risk, while midlines allow dwell up to 29 days with guidewire-assisted placement to improve insertion success.
Emergency intraosseous access (Arrow EZ-IO) and antimicrobial-impregnated short-term CVCs (Arrowg+ard Blue Plus) covering difficult access and high infection-risk patients. IO enables access in about 10 seconds with high first-attempt success, while chlorhexidine/silver-sulfadiazine CVCs suppress microbial colonization and reduce catheter-related bloodstream infections.
Antimicrobial hemodialysis catheter caps (ClearGuard HD) standardize line access and protect catheter hubs. Straight fluid path minimize reflux/occlusion and provide a microbial barrier, while ClearGuard HD caps achieved significant CLABSI reductions in multicenter randomized trials.
Peripheral IV catheters with ultra-sharp three-bevel needles, thin-wall flexible cannulae, and flashback chamber for rapid venous confirmation and comfortable placement. Design targets smooth insertion, kink resistance, and patient comfort to support reliable drug, fluid, and blood administration across care settings.
The portfolio holds midlines (Smartmidline, Lifecath Midline) as the trusted peripheral venous access for a maximum of 29 days, and PICC lines (Lifecath PICC range, CT PICC) as medium-to-long term access to central veins; furthermore, these are complemented by the insertion sets for PICC/Midline which provide standardized placement. Midlines lessen the need for frequent re-siting and support longer dwell time as compared to short PIVs, thus helping reduce venous trauma; PICC lines make it possible for stable long-term infusion therapy, and dedicated insertion packs support aseptic, consistent workflows as well as improved procedural efficiency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The market ecosystem for vascular access devices consists of device manufacturers, regulatory authorities, and end users. The main participants are medical device manufacturers that provide PICC lines, CVCs, implantable ports, peripheral IV catheters, and other vascular access devices for various patients' needs, such as peripherally inserted central catheters (PICC), central venous catheters (CVC), and so on. Regulatory authorities like the FDA, the European Commission, and the CDSCO have an important role in product safety and efficacy. There is going to be a strong comeback of ongoing technological improvements, such as ultrasonic-assisted placement and antimicrobial coatings, through better patient outcomes and fewer complications. Specialty clinics and home care providers are among the main users of these devices, while reimbursement policies have a major impact on adoption. Market dynamics are influenced by mergers and acquisitions, partnerships, and geographic expansions. North America is estimated to be the largest market, while Asia Pacific is projected to experience the fastest growth due to improving healthcare infrastructure. All in all, continuous R&D investments, strategic partnerships, and a keen focus on patient-centered innovation are the main factors driving the vascular access device market.

vascular-access-device-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

vascular-access-device-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Vascular Access Device Market, By Type

Based on type, the vascular access device market is divided into central venous access devices, peripheral vascular access devices, intraosseous vascular access devices, and accessories. Among these, the central venous access devices segment accounted for the largest market share in 2025 due to the increasing prevalence of diseases requiring vascular access devices, such as cancer, chronic kidney diseases (CKDs), and CVDs.

Vascular Access Device Market, By Route of Insertion

Based on route of insertion, the market is segmented into intravenous route of insertion (IV), subcutaneous route of insertion, and intraosseous route of insertion. The expansion of the intravenous route of insertion is largely attributed to factors such as quick delivery of the drug, maximum bioavailability, and compatibility with the administration of fluids, drugs, blood products, and chemotherapy in both acute and chronic care environments. Besides, its user-friendliness, vast clinical applicability, and general acceptance in hospitals, clinics, and home healthcare are adding to the market growth.

Vascular Access Device Market, By Application

Based on application, the market is segmented into drug administration, food & nutrition administration, blood transfusion, and diagnostics & testing. In 2025, the drug administration segment led the market, primarily due to the increasing application of intravenous therapy in chronic diseases and infections, where timely and accurate drug delivery is crucial.

Vascular Access Device Market, By End User

Based on end user, the market is classified into hospitals, clinics & ambulatory care centers, and other end users (including nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment accounted for the largest market share in 2025 due to rising funding programs to build infrastructure in rural and underserved areas and the increasing prevalence of diseases necessitating vascular access devices.

REGION

Asia Pacific to be fastest-growing region in global vascular access device market during forecast period.

The Asia Pacific (APAC) region is projected to be the fastest-growing market for vascular access devices globally, mainly due to the increasing occurrence of chronic diseases, which include cancer, diabetes, and cardiovascular disorders, as well as an overall large and aged patient population. Urbanization, lifestyle changes, hospitalizations, and the need for long-term intravenous therapies are some of the factors significantly increasing the demand for vascular access solutions in China, India, Japan, South Korea, and Southeast Asian countries. The healthcare infrastructure in the region is undergoing a rapid change with the introduction of advanced technologies like ultrasound-guided vascular access, antimicrobial-coated catheters, and safety-engineered devices in hospitals, specialty clinics, dialysis centers, and infusion facilities. Rising healthcare expenditure, broader insurance coverage through public and private schemes, and capital investment by governments to strengthen hospital and outpatient care are other factors driving the market. The increasing presence of global manufacturers through local production, partnerships, and distribution networks is also positioning APAC as one of the fastest-growing regions in the global vascular access device market.

vascular-access-device-market Region

VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX

The vascular access device market is characterized by strong competition among leading players such as Becton Dickinson & Company, Teleflex Incorporated, ICU Medical, Nipro Corporation, and Vygon. Becton Dickinson holds a dominant position due to its extensive vascular access device portfolio, robust R&D capabilities, and widespread global presence. Teleflex and ICU Medical are focusing on innovation through advanced product launches, collaborations, and acquisitions to expand their market reach. Meanwhile, Nipro and Vygon maintain steady growth by offering comprehensive product lines across multiple regions, catering to diverse clinical requirements and strengthening their international footprint.

vascular-access-device-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 5.92 BN
Market Forecast in 2031 (Value) USD 8.68 BN
Growth Rate CAGR of 6.7% from 2026 to 2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Billion), Volume (Thousand/Million Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Type:
    • Central Venous Access Device
    • Peripheral Vascular Access Device
    • Intraosseous Vascular Access Device
    • Accessories
  • By Route of Insertion:
    • Intravenous
    • Subcutaneous
    • Intraosseous
  • By Application:
    • Drug Administration
    • Fluid & Nutrition Administration
    • Blood Transfusion
    • Diagnostic & Testing
  • By End User:
    • Hospitals
    • Ambulatory Care Centers & Clinics
    • Other End Users
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: VASCULAR ACCESS DEVICE MARKET REPORT CONTENT GUIDE

vascular-access-device-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis A thorough assessment of the essential vascular access device types was performed throughout the worldwide market, which included peripheral IV catheters, central venous catheters (CVCs), peripherally inserted central catheters (PICCs). The analysis reviewed significant technological developments such as antimicrobial and antithrombogenic coatings, safety-engineered designs, ultrasound-guided insertion, and power-injectable devices. In addition, regulatory pathways (FDA PMA and 510(k)), reimbursement frameworks, infection prevention outcomes, device longevity, and product differentiation strategies adopted by leading manufacturers were evaluated to comprehend market competitiveness and innovative directions. The healthcare professionals and stakeholders succeeded in pinpointing the most effective vascular access technologies from both the clinical and commercial perspectives by correlating device performance with the actual outcomes, reduction of infection risks, the preferred choice of clinicians, and the level of patient acuity. The acquired knowledge not only helped in developing portfolio strategies but also played a role in the decision-making on technology adoption and in syncing product development with the trends of outpatient infusion therapy, home healthcare expansion, and long-term vascular access safety.
Company Information Major global and regional players in the vascular access device market, such as Becton, Dickinson and Company (BD), B. Braun, Teleflex, Medtronic, Smiths Medical, and Cook Medical, as well as emerging regional manufacturers, were thoroughly profiled. The evaluation included a wide range of elements such as product portfolios, patented technologies, R&D pipelines, clinical evidence, manufacturing sites, regulatory approvals, commercialization strategies, and partnerships. Competitive positioning was analyzed for both peripheral and central access segments, taking into account recent mergers, acquisitions, licensing deals, and co-development initiatives. The analysis revealed the competitive dynamics, technological leadership, and ecosystem partnerships within the vascular access landscape. Clients were able to see the opportunities for collaboration, acquisition targets, distribution partnerships, and long-term growth strategies, while portfolio scarcity and differentiation opportunities in high-growth segments such as antimicrobial catheters, PICCs, and home-use vascular access solutions were being pinpointed.
Geographic Analysis The market of vascular access devices was examined according to the major regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The analysis took into account the different factors such as the prevalence of diseases, the number of procedures done, the level of maturity of the healthcare infrastructure, the reimbursement environments, the availability of clinicians, the standards of infection control, and the trend toward outpatient and home-based care. Moreover, regional manufacturing hubs, innovation clusters, and R&D centers were scrutinized, along with country-level deep dives and global benchmarking based on client requirements. The regional assessment supported the company's market planning by highlighting the geographical areas with the highest growth, the key procedural hotspots, and the most favorable reimbursement landscapes. The clients were in the position to streamline their market entry and expansion plans, improve their sales and distribution models, choose the best places for conducting clinical trials, and work with top hospitals, infusion centers, and home healthcare providers—all of which were part of the strategy to take advantage of the increasing demand for advanced vascular access solutions in both developing and developed markets.

RECENT DEVELOPMENTS

  • October 2025 : B. Braun announced the expansion of its vascular access product line, which now includes a new central venous catheter of an innovative generation equipped with superior antithrombogenic and antimicrobial coatings, intended for cutting down catheter-related bloodstream infections (CRBSIs) in patients with high risk, such as those in the ICU and oncology.
  • June 2025 : Becton, Dickinson, and Company (BD) introduced a new state-of-the-art peripheral IV catheter platform having antimicrobial technology incorporated with better securement features, which will help in decreasing bloodstream infections related to catheters and increasing their staying time in hospitals and clinics.
  • February 2024 : Teleflex Incorporated received regulatory clearance in the US for an upgraded peripherally inserted central catheter (PICC) system designed for ultrasound-guided placement and power injection. The new system enhances clinicians' ease of use and supports growing demand for PICCs in chemotherapy, critical care, and long-term drug administration.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
41
2
RESEARCH METHODOLOGY
 
 
 
46
3
EXECUTIVE SUMMARY
 
 
 
60
4
PREMIUM INSIGHTS
 
 
 
68
5
MARKET OVERVIEW
Unlock growth potential with cutting-edge vascular access technologies amidst rising healthcare demands and challenges.
 
 
 
72
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
GROWING PREVALENCE OF LIFESTYLE DISEASES
 
 
 
 
5.2.1.2
INCREASING POPULARITY OF CHEMOTHERAPY PROCEDURES AMONG CANCER PATIENTS
 
 
 
 
5.2.1.3
RISING USE OF VASCULAR ACCESS DEVICES AMONG PEDIATRIC PATIENTS
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH COST OF INSTALLATION AND MAINTENANCE OF VASCULAR ACCESS DEVICES
 
 
 
 
5.2.2.2
RISING PRODUCT RECALLS AND FAILURES
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
TECHNOLOGICAL ADVANCEMENTS
 
 
 
 
5.2.3.2
INCREASING NUMBER OF HOSPITALS AND EXPANDING PATIENT POOL
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS
 
 
 
 
5.2.4.2
RISKS ASSOCIATED WITH USE OF VASCULAR ACCESS DEVICES
 
 
5.3
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.3.1
KEY TECHNOLOGIES
 
 
 
 
 
5.3.1.1
IMAGING AND NAVIGATION TECHNOLOGIES
 
 
 
 
5.3.1.2
CATHETER SECUREMENT AND STABILIZATION TECHNOLOGIES
 
 
 
5.3.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.3.2.1
AI AND ML
 
 
 
5.3.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.3.3.1
INFECTION CONTROL TECHNOLOGIES
 
 
5.4
INDUSTRY TRENDS
 
 
 
 
 
5.4.1
MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
 
 
 
 
5.4.2
INNOVATIONS IN CATHETER MATERIALS AND COATINGS
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.6.1
ROLE IN ECOSYSTEM
 
 
 
5.7
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
5.8.1
IMPORT DATA FOR HS CODE 901839
 
 
 
 
5.8.2
EXPORT DATA FOR HS CODE 901839
 
 
 
5.9
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.9.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.9.2
THREAT OF SUBSTITUTES
 
 
 
 
5.9.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.9.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.10
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.10.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.10.2
KEY BUYING CRITERIA
 
 
 
5.11
REGULATORY ANALYSIS
 
 
 
 
 
5.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.11.2
REGULATORY FRAMEWORK
 
 
 
 
 
5.11.2.1
NORTH AMERICA
 
 
 
 
5.11.2.2
EUROPE
 
 
 
 
5.11.2.3
ASIA PACIFIC
 
 
 
 
5.11.2.4
LATIN AMERICA
 
 
 
 
5.11.2.5
MIDDLE EAST & AFRICA
 
 
5.12
PATENT ANALYSIS
 
 
 
 
 
 
5.12.1
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
5.13
PRICING ANALYSIS
 
 
 
 
 
 
5.13.1
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
 
 
 
 
5.13.2
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
 
 
 
5.14
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.15
ADJACENT MARKET ANALYSIS
 
 
 
 
 
5.15.1
VASCULAR CLOSURE DEVICES MARKET
 
 
 
5.16
UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
5.17
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
5.18
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
5.19
IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
 
 
 
 
6
VASCULAR ACCESS DEVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 40 Data Tables
 
 
 
104
 
6.1
INTRODUCTION
 
 
 
 
6.2
CENTRAL VENOUS ACCESS DEVICES
 
 
 
 
 
6.2.1
PERIPHERALLY INSERTED CENTRAL CATHETERS
 
 
 
 
 
6.2.1.1
BETTER DURABILITY AND INCREASED CLINICAL UTILITY FOR EXTENDED TREATMENT PLANS TO DRIVE SEGMENT
 
 
 
6.2.2
TUNNELED CATHETERS
 
 
 
 
 
6.2.2.1
LOWER RISK OF INFECTION AND SUPERIOR LONGEVITY TO SUPPORT SEGMENT GROWTH
 
 
 
6.2.3
NON-TUNNELED CATHETERS
 
 
 
 
 
6.2.3.1
NON-TUNNELED CATHETERS TO BE USED IN CRITICAL CASES WITH LIMITED PERIPHERAL ACCESS
 
 
 
6.2.4
IMPLANTABLE PORTS
 
 
 
 
 
6.2.4.1
IMPLANTABLE CONVENTIONAL PORTS
 
 
 
 
6.2.4.2
IMPLANTABLE POWER INJECTABLE PORTS
 
 
6.3
PERIPHERAL VASCULAR ACCESS DEVICES
 
 
 
 
 
6.3.1
PERIPHERAL VENOUS ACCESS DEVICES
 
 
 
 
 
6.3.1.1
PERIPHERAL INTRAVENOUS CATHETERS
 
 
 
 
6.3.1.2
MIDLINE CATHETERS
 
 
 
 
6.3.1.3
BUTTERFLY/WINGED STEEL NEEDLES
 
 
 
6.3.2
PERIPHERAL ARTERIAL ACCESS DEVICES
 
 
 
 
 
6.3.2.1
CRITICAL ROLE IN CONTINUOUS HEMODYNAMIC MONITORING AND BLOOD SAMPLING IN ACUTE CARE SETTINGS TO PROPEL SEGMENT GROWTH
 
 
6.4
ACCESSORIES
 
 
 
 
 
6.4.1
NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
 
 
 
6.5
INTRAOSSEOUS VASCULAR ACCESS DEVICES
 
 
 
 
 
6.5.1
CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES
 
 
7
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
 
 
 
140
 
7.1
INTRODUCTION
 
 
 
 
7.2
INTRAVENOUS ROUTE OF INSERTION
 
 
 
 
 
7.2.1
RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
 
 
 
7.3
SUBCUTANEOUS ROUTE OF INSERTION
 
 
 
 
 
7.3.1
REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
 
 
 
7.4
INTRAOSSEOUS ROUTE OF INSERTION
 
 
 
 
 
7.4.1
NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE
 
 
8
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables
 
 
 
148
 
8.1
INTRODUCTION
 
 
 
 
8.2
DRUG ADMINISTRATION
 
 
 
 
 
8.2.1
CHEMOTHERAPY
 
 
 
 
 
8.2.1.1
INCREASED INCIDENCE OF CANCER AND ADVANCEMENTS IN ONCOLOGY CARE TO DRIVE SEGMENT
 
 
 
8.2.2
OTHER DRUG ADMINISTRATION
 
 
 
8.3
FLUID & NUTRITION ADMINISTRATION
 
 
 
 
 
8.3.1
INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
 
 
 
8.4
BLOOD TRANSFUSION
 
 
 
 
 
8.4.1
FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
 
 
 
8.5
DIAGNOSTICS & TESTING
 
 
 
 
 
8.5.1
INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH
 
 
9
VASCULAR ACCESS DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
 
 
 
163
 
9.1
INTRODUCTION
 
 
 
 
9.2
HOSPITALS
 
 
 
 
 
9.2.1
PUBLIC HOSPITALS
 
 
 
 
 
9.2.1.1
INCREASING DEMAND FOR AFFORDABLE HEALTHCARE SERVICES IN EMERGING ECONOMIES TO DRIVE SEGMENT
 
 
 
9.2.2
PRIVATE HOSPITALS
 
 
 
 
 
9.2.2.1
RISING DEMAND FOR ADVANCED HEALTHCARE SERVICES AND HIGH-QUALITY TREATMENT OPTIONS TO DRIVE MARKET
 
 
9.3
CLINICS & AMBULATORY CARE CENTERS
 
 
 
 
 
9.3.1
INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
 
 
 
9.4
OTHER END USERS
 
 
 
10
VASCULAR ACCESS DEVICES MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 508 Data Tables.
 
 
 
174
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
US TO DOMINATE NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET DURING FORECAST PERIOD
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
RISING CANCER PREVALENCE AND ADVANCED RESEARCH INITIATIVES TO PROPEL MARKET GROWTH
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
RISING OBESITY RATES AND GROWING GERIATRIC POPULATION TO AUGMENT MARKET GROWTH
 
 
 
10.3.3
UK
 
 
 
 
 
10.3.3.1
INCREASED DISEASE BURDEN TO FUEL UPTAKE FOR ADVANCED VASCULAR ACCESS DEVICES FOR BETTER TREATMENT PROCEDURES
 
 
 
10.3.4
FRANCE
 
 
 
 
 
10.3.4.1
PRESENCE OF VASCULAR ACCESS DEVICE MANUFACTURERS AND TECHNOLOGICAL ADVANCEMENTS TO FUEL MARKET GROWTH
 
 
 
10.3.5
ITALY
 
 
 
 
 
10.3.5.1
STRONG GOVERNMENT HEALTHCARE POLICIES TO BOOST MARKET GROWTH
 
 
 
10.3.6
SPAIN
 
 
 
 
 
10.3.6.1
GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH
 
 
 
10.3.7
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
10.4.2
CHINA
 
 
 
 
 
10.4.2.1
ADVANCED HEALTHCARE INFRASTRUCTURE AND HIGH GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
 
 
 
10.4.3
INDIA
 
 
 
 
 
10.4.3.1
RISING GOVERNMENTAL HEALTH EXPENDITURE AND INCREASING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH
 
 
 
10.4.4
JAPAN
 
 
 
 
 
10.4.4.1
INCREASED GERIATRIC POPULATION AND HIGH PREVALENCE OF CANCER TO DRIVE MARKET
 
 
 
10.4.5
AUSTRALIA
 
 
 
 
 
10.4.5.1
INCREASED DEMAND FOR HEMODIALYSIS AND ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
 
 
 
10.4.6
SOUTH KOREA
 
 
 
 
 
10.4.6.1
RISING BURDEN OF CHRONIC DISEASES AND INCREASING AGED POPULATION TO BOOST MARKET GROWTH
 
 
 
10.4.7
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
10.5.2
BRAZIL
 
 
 
 
 
10.5.2.1
GROWING CANCER BURDEN AND RISING NEED FOR LONG-TERM TREATMENT FOR CHRONIC PATIENTS TO DRIVE MARKET
 
 
 
10.5.3
MEXICO
 
 
 
 
 
10.5.3.1
INCREASING FOCUS ON DIALYSIS FOR PATIENTS WITH CHRONIC KIDNEY DISEASES TO DRIVE ADOPTION OF ADVANCED VASCULAR ACCESS DEVICES
 
 
 
10.5.4
REST OF LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
10.6.2
GCC COUNTRIES
 
 
 
 
 
10.6.2.1
INCREASING HEALTHCARE INVESTMENTS AND RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
 
 
 
10.6.3
REST OF MIDDLE EAST & AFRICA
 
 
11
COMPETITIVE LANDSCAPE
Discover leading strategies and market positions shaping the vascular access devices competitive landscape.
 
 
 
357
 
11.1
INTRODUCTION
 
 
 
 
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
 
 
 
11.3
REVENUE ANALYSIS, 2019–2023
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2023
 
 
 
 
 
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
11.5.1
STARS
 
 
 
 
11.5.2
EMERGING LEADERS
 
 
 
 
11.5.3
PERVASIVE PLAYERS
 
 
 
 
11.5.4
PARTICIPANTS
 
 
 
 
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
11.5.5.1
COMPANY FOOTPRINT
 
 
 
 
11.5.5.2
REGION FOOTPRINT
 
 
 
 
11.5.5.3
TYPE FOOTPRINT
 
 
 
 
11.5.5.4
ROUTE OF INSERTION FOOTPRINT
 
 
 
 
11.5.5.5
APPLICATION FOOTPRINT
 
 
 
 
11.5.5.6
END-USER FOOTPRINT
 
 
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
11.6.1
PROGRESSIVE COMPANIES
 
 
 
 
11.6.2
RESPONSIVE COMPANIES
 
 
 
 
11.6.3
DYNAMIC COMPANIES
 
 
 
 
11.6.4
STARTING BLOCKS
 
 
 
 
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
 
 
11.6.5.1
DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
 
 
11.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
11.7.1
FINANCIAL METRICS
 
 
 
 
11.7.2
COMPANY VALUATION
 
 
 
11.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
11.9.2
DEALS
 
 
 
 
11.9.3
OTHER DEVELOPMENTS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
378
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
BECTON, DICKINSON AND COMPANY
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
TELEFLEX INCORPORATED
 
 
 
 
12.1.3
ICU MEDICAL
 
 
 
 
12.1.4
NIPRO
 
 
 
 
12.1.5
ANGIODYNAMICS, INC.
 
 
 
 
12.1.6
VYGON
 
 
 
 
12.1.7
TERUMO CORPORATION
 
 
 
 
12.1.8
MEDTRONIC PLC
 
 
 
 
12.1.9
COOK
 
 
 
 
12.1.10
B. BRAUN SE
 
 
 
 
12.1.11
MERIT MEDICAL SYSTEMS, INC.
 
 
 
 
12.1.12
AMECATH
 
 
 
 
12.1.13
MEDICAL COMPONENTS, INC.
 
 
 
 
12.1.14
HEALTHLINE MEDICAL PRODUCTS
 
 
 
 
12.1.15
ACCESS VASCULAR, INC.
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
ARGON MEDICAL DEVICES
 
 
 
 
12.2.2
PAKUMEDMEDICAL PRODUCTS GMBH
 
 
 
 
12.2.3
GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
12.2.4
PFM MEDICAL GMBH
 
 
 
 
12.2.5
MEDI-TECH DEVICES PVT. LTD.
 
 
 
 
12.2.6
KIMAL
 
 
 
 
12.2.7
POLYMEDICURE
 
 
 
 
12.2.8
DELTAMED
 
 
 
 
12.2.9
NEWTECH MEDICAL DEVICES PVT. LTD.
 
 
 
 
12.2.10
SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
 
 
13
APPENDIX
 
 
 
449
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
CUSTOMIZATION OPTIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
TABLE 2
STANDARD CURRENCY CONVERSION RATES
 
 
 
 
TABLE 3
VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS
 
 
 
 
TABLE 4
VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
 
 
 
 
TABLE 5
VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
 
 
 
 
TABLE 6
IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
 
 
 
 
TABLE 7
EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
 
 
 
 
TABLE 8
VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES
 
 
 
 
TABLE 9
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
 
 
 
 
TABLE 10
KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES
 
 
 
 
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 16
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
 
 
 
 
TABLE 17
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
 
 
 
 
TABLE 18
VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
 
 
 
 
TABLE 19
VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
TABLE 20
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 21
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 22
CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 23
CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 24
CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 25
CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 26
PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 27
PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 28
TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 29
TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 30
NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 31
NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 32
IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 33
IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 34
IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 35
IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 36
IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 37
IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 38
IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 39
IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 40
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 41
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 42
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 43
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 44
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 45
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 46
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 47
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 48
PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 49
PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 50
MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 51
MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 52
BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 53
BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 54
PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 55
PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 56
ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 57
ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 58
INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 59
INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 60
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 61
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 62
VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 63
VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 64
VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 65
VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 66
VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 67
VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 68
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 69
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 70
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 71
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 72
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 73
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 74
VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 75
VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 76
VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 77
VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 78
VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 79
VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 80
VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 81
VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 82
VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 83
VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 84
VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 85
VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 86
VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 87
VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 88
PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 89
PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 90
PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 91
PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 92
VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 93
VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 94
VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 95
VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 96
VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 97
VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION)
 
 
 
 
TABLE 98
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 99
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 100
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 101
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 102
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 103
NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 104
NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 105
NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 106
NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 107
NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 108
NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 109
NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 110
NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 111
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 112
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 114
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 115
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 116
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 117
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 118
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 119
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 120
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 121
US: KEY MACROINDICATORS
 
 
 
 
TABLE 122
US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 123
US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 124
US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 125
US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 126
US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 127
US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 128
US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 129
US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 130
US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 131
US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 132
US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 133
US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 134
US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 135
US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 136
US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 137
US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 138
US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 139
US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 140
US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 141
US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 142
CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024
 
 
 
 
TABLE 143
CANADA: KEY MACROINDICATORS
 
 
 
 
TABLE 144
CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 145
CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 146
CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 147
CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 148
CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 149
CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 150
CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 151
CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 152
CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 153
CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 154
CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 155
CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 156
CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 157
CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 158
CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 159
CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 160
CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 161
CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 162
CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 163
CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 165
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 166
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 167
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 168
EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 169
EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 170
EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 171
EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 172
EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 173
EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 174
EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 175
EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 176
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 177
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 178
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 179
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 180
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 181
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 182
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 183
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 184
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 185
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 186
GERMANY: KEY MACROINDICATORS
 
 
 
 
TABLE 187
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 188
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 189
GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 190
GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 191
GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 192
GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 193
GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 194
GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 195
GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 196
GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 197
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 198
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 199
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 200
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 201
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 202
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 203
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 204
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 205
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 206
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 207
UK: KEY MACROINDICATORS
 
 
 
 
TABLE 208
UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 209
UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 210
UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 211
UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 212
UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 213
UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 214
UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 215
UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 216
UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 217
UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 218
UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 219
UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 220
UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 221
UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 222
UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 223
UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 224
UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 225
UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 226
UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 227
UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 228
FRANCE: KEY MACROINDICATORS
 
 
 
 
TABLE 229
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 230
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 231
FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 232
FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 233
FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 234
FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 235
FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 236
FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 237
FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 238
FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 239
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 240
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 241
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 242
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 243
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 244
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 245
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 246
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 247
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 248
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 249
ITALY: KEY MACROINDICATORS
 
 
 
 
TABLE 250
ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 251
ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 252
ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 253
ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 254
ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 255
ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 256
ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 257
ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 258
ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 259
ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 260
ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 261
ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 262
ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 263
ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 264
ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 265
ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 266
ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 267
ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 268
ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 269
ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 270
SPAIN: KEY MACROINDICATORS
 
 
 
 
TABLE 271
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 272
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 273
SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 274
SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 275
SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 276
SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 277
SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 278
SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 279
SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 280
SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 281
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 282
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 283
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 284
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 285
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 286
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 287
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 288
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 289
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 290
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 291
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 292
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 293
REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 294
REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 295
REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 296
REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 297
REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 298
REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 299
REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 300
REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 301
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 302
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 303
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 304
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 305
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 306
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 307
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 308
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 309
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 310
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 311
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 312
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 313
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 314
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 315
ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 316
ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 317
ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 318
ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 319
ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 320
ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 321
ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 322
ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 323
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 324
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 325
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 326
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 327
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 328
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 329
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 330
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 331
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 332
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 333
CHINA: KEY MACROINDICATORS
 
 
 
 
TABLE 334
CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 335
CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 336
CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 337
CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 338
CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 339
CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 340
CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 341
CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 342
CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 343
CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 344
CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 345
CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 346
CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 347
CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 348
CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 349
CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 350
CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 351
CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 352
CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 353
CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 354
INDIA: KEY MACROINDICATORS
 
 
 
 
TABLE 355
INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 356
INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 357
INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 358
INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 359
INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 360
INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 361
INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 362
INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 363
INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 364
INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 365
INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 366
INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 367
INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 368
INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 369
INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 370
INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 371
INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 372
INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 373
INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 374
INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 375
JAPAN: KEY MACROINDICATORS
 
 
 
 
TABLE 376
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 377
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 378
JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 379
JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 380
JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 381
JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 382
JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 383
JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 384
JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 385
JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 386
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 387
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 388
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 389
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 390
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 391
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 392
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 393
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 394
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 395
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 396
AUSTRALIA: KEY MACROINDICATORS
 
 
 
 
TABLE 397
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 398
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 399
AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 400
AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 401
AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 402
AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 403
AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 404
AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 405
AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 406
AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 407
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 408
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 409
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 410
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 411
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 412
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 413
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 414
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 415
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 416
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 417
SOUTH KOREA: KEY MACROINDICATORS
 
 
 
 
TABLE 418
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 419
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 420
SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 421
SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 422
SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 423
SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 424
SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 425
SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 426
SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 427
SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 428
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 429
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 430
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 431
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 432
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 433
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 434
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 435
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 436
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 437
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 438
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 439
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 440
REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 441
REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 442
REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 443
REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 444
REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 445
REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 446
REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 447
REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 448
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 449
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 450
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 451
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 452
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 453
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 454
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 455
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 456
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 457
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 458
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 459
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 460
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 461
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 462
LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 463
LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 464
LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 465
LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 466
LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 467
LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 468
LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 469
LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 470
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 471
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 472
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 473
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 474
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 475
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 476
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 477
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 478
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 479
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 480
BRAZIL: KEY MACROINDICATORS
 
 
 
 
TABLE 481
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 482
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 483
BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 484
BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 485
BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 486
BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 487
BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 488
BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 489
BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 490
BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 491
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 492
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 493
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 494
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 495
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 496
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 497
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 498
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 499
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 500
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 501
MEXICO: KEY MACROINDICATORS
 
 
 
 
TABLE 502
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 503
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 504
MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 505
MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 506
MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 507
MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 508
MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 509
MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 510
MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 511
MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 512
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 513
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 514
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 515
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 516
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 517
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 518
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 519
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 520
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 521
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 522
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 523
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 524
REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 525
REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 526
REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 527
REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 528
REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 529
REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 530
REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 531
REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 532
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 533
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 534
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 535
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 536
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 537
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 538
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 539
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 540
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 541
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 542
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 543
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 544
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 545
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 546
MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 547
MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 548
MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 549
MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 550
MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 551
MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 552
MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 553
MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 554
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 555
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 556
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 557
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 558
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 559
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 560
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 561
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 562
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 563
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 564
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 565
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 566
GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 567
GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 568
GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 569
GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 570
GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 571
GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 572
GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 573
GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 574
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 575
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 576
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 577
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 578
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 579
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 580
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 581
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 582
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 583
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 584
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 585
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 586
REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 587
REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 588
REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 589
REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 590
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 591
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 592
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 593
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 594
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 595
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 596
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 597
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 598
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 599
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 600
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 601
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 602
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 603
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 604
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
 
 
 
 
TABLE 605
VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 606
VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 607
VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
 
 
 
 
TABLE 608
VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
 
 
 
 
TABLE 609
VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 610
VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 611
VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
TABLE 612
VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
 
 
 
 
TABLE 613
VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 614
VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 615
VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 616
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
 
 
 
 
TABLE 617
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
 
 
 
 
TABLE 618
BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 619
TELEFLEX INCORPORATED: COMPANY OVERVIEW
 
 
 
 
TABLE 620
TELEFLEX INCORPORATED: PRODUCTS OFFERED
 
 
 
 
TABLE 621
TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 622
TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 623
ICU MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 624
ICU MEDICAL: PRODUCTS OFFERED
 
 
 
 
TABLE 625
ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 626
NIPRO: COMPANY OVERVIEW
 
 
 
 
TABLE 627
NIPRO: PRODUCTS OFFERED
 
 
 
 
TABLE 628
ANGIODYNAMICS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 629
ANGIODYNAMICS, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 630
ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 631
ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 632
VYGON: COMPANY OVERVIEW
 
 
 
 
TABLE 633
VYGON: PRODUCTS OFFERED
 
 
 
 
TABLE 634
TERUMO CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 635
TERUMO CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 636
MEDTRONIC PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 637
MEDTRONIC PLC: PRODUCTS OFFERED
 
 
 
 
TABLE 638
COOK: COMPANY OVERVIEW
 
 
 
 
TABLE 639
COOK: PRODUCTS OFFERED
 
 
 
 
TABLE 640
B. BRAUN SE: COMPANY OVERVIEW
 
 
 
 
TABLE 641
B. BRAUN SE: PRODUCTS OFFERED
 
 
 
 
TABLE 642
B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 643
B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 644
MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 645
MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 646
MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 647
AMECATH: COMPANY OVERVIEW
 
 
 
 
TABLE 648
AMECATH: PRODUCTS OFFERED
 
 
 
 
TABLE 649
MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 650
MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 651
HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
 
 
 
 
TABLE 652
HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
 
 
 
 
TABLE 653
ACCESS VASCULAR, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 654
ACCESS VASCULAR, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 655
ARGON MEDICAL DEVICES: COMPANY OVERVIEW
 
 
 
 
TABLE 656
PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 657
GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 658
PFM MEDICAL GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 659
MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 660
KIMAL: COMPANY OVERVIEW
 
 
 
 
TABLE 661
POLYMEDICURE: COMPANY OVERVIEW
 
 
 
 
TABLE 662
DELTAMED: COMPANY OVERVIEW
 
 
 
 
TABLE 663
NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 664
SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
VASCULAR ACCESS DEVICES MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
 
 
 
 
FIGURE 2
VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED
 
 
 
 
FIGURE 3
VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 4
VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
 
 
 
 
FIGURE 5
VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES
 
 
 
 
FIGURE 6
VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
FIGURE 7
VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 9
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
 
 
 
 
FIGURE 10
VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
 
 
 
 
FIGURE 12
IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET
 
 
 
 
FIGURE 13
VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS
 
 
 
 
FIGURE 14
VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION
 
 
 
 
FIGURE 15
CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
 
 
 
 
FIGURE 16
TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
 
 
 
 
FIGURE 17
IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
 
 
 
 
FIGURE 18
PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 19
PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
 
 
 
 
FIGURE 20
INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
 
 
 
 
FIGURE 21
DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
 
 
 
 
FIGURE 22
CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
 
 
 
 
FIGURE 23
HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 24
PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 25
ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
 
 
 
 
FIGURE 26
RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET
 
 
 
 
FIGURE 27
US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023
 
 
 
 
FIGURE 28
ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 29
ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030
 
 
 
 
FIGURE 30
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
 
 
 
 
FIGURE 31
VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 32
VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 33
VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 34
VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 35
VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 36
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
 
 
 
 
FIGURE 37
KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES
 
 
 
 
FIGURE 38
NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)
 
 
 
 
FIGURE 39
TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014−DECEMBER 2024)
 
 
 
 
FIGURE 40
TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014− DECEMBER 2024)
 
 
 
 
FIGURE 41
VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW
 
 
 
 
FIGURE 42
VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
FIGURE 43
VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023
 
 
 
 
FIGURE 44
VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
 
 
 
 
FIGURE 45
VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
FIGURE 46
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 47
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 48
REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)
 
 
 
 
FIGURE 49
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
 
 
 
 
FIGURE 50
VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
 
 
 
 
FIGURE 51
VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 52
VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 53
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 54
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 55
VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 56
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
TELEFLEX INCORPORATED: COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
ICU MEDICAL: COMPANY SNAPSHOT
 
 
 
 
FIGURE 59
NIPRO: COMPANY SNAPSHOT
 
 
 
 
FIGURE 60
ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 61
TERUMO CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 62
MEDTRONIC PLC: COMPANY SNAPSHOT
 
 
 
 
FIGURE 63
B. BRAUN SE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 64
MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
 
 
 
 

Methodology

This study involved four major activities in estimating the size of the vascular access device market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step involved validating these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the vascular access device market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vascular access device market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief executive officers (CXOs), vice presidents (VPs), directors from business development, marketing, and product development/innovation teams, related key executives from manufacturers and distributors operating in the market, and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side (customers/end users) were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage, and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents.

Vascular Access Device Market Size, and Share

Note: Companies are classified into tiers based on their total revenue. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. C-level primaries include CEOs, COOs, CTOs, and VPs. Other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the vascular access device market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the vascular access device market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall market was obtained from secondary data and validated by primary participants to arrive at the total market. Primary participants further validated the numbers.

Geographic Market Assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall vascular access device market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Vascular Access Device Market : Top-Down and Bottom-Up Approach

Vascular Access Device Market Top Down and Bottom Up Approach

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size, using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the vascular access device market.

Market Definition

A vascular access device (VAD) is a device that is surgically implanted into a vein or artery, which allows for direct blood flow access for either diagnostic or therapeutic purposes. Its primary use is in the delivery of drugs, blood products, fluids, and nutritional support, in addition to the occasional blood sampling.

For patients receiving long-term IV treatments, such as chemotherapy or dialysis, vascular access devices are essential. According to the insertion site and duration of use, VADs are divided into two categories: central and peripheral. The insertion points for these devices are usually in the arm, chest, or leg, and sometimes they are left in place for quite a long time, depending on the patient's clinical condition.

Key Stakeholders

  • Vascular access device manufacturers and distributors
  • Interventional cardiology vascular device manufacturers
  • Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
  • Healthcare institutions (hospitals and outpatient clinics)
  • Distributors and suppliers
  • Research institutes
  • Health insurance payers
  • World Health Organization (WHO)
  • Organization for Economic Co-operation and Development (OECD)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles
  • Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg Business

Report Objectives

  • To define, describe, segment, and forecast the vascular access device market by type, route of insertion, application, end user, and region
  • To provide detailed information about the factors influencing the vascular access device market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall vascular access device market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players in the vascular access device market
  • To forecast the size of the vascular access device market in five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
  • To profile key players in the vascular access device market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, collaborations, and product launches/approvals in the vascular access device market
  • To benchmark players within the vascular access device market using the "Company Evaluation Matrix" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific vascular access device market into Thailand, Indonesia, the Philippines, Vietnam, Hong Kong, and other countries
  • Further breakdown of the Rest of Europe vascular access device market into Belgium, Russia, the Netherlands, Switzerland, and other countries.

 

Key Questions Addressed by the Report

Which are the top industry players in the global vascular access devices market?
The top market players in the global vascular access device market include The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), and Nipro (Japan)
What are some of the major drivers for this market?
Growth in the vascular access devices market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, the increasing number of chemotherapy procedures, and the growing use of vascular access devices in pediatric patients.
Which end users have been included in the global vascular access devices market?
This report contains the following end user segments:
  • Hospitals
  • Clinics & Ambulatory Care Centers
  • Other End Users
Which type of vascular access device is lucrative for the vascular access devices market?
The peripheral vascular access devices segment is expected to witness the highest growth rate during the forecast period.
Which region is lucrative for the vascular access device market?
The Asia Pacific market is expected to witness the highest CAGR during the forecast period.

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vascular Access Device Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vascular Access Device Market

DMCA.com Protection Status